Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
Status:
Active, not recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor
cells, either by killing the cells or by stopping them from dividing. Giving more than one
drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This randomized phase III trial is comparing two different combination chemotherapy
regimens to see how well they work in treating patients with stage II or stage III
non-seminomatous germ cell tumors.